Proqr Therapeutics Nv logo

Proqr Therapeutics Nv share price today

(PRQR)

Proqr Therapeutics Nv share price is $2.62 & ₹224.82 as on 7 Jan 2025, 2.30 'hrs' IST

$2.62

-0.14

(-5.07%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Proqr Therapeutics Nv share price in Dollar and Rupees. Guide to invest in Proqr Therapeutics Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Proqr Therapeutics Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Proqr Therapeutics Nv share price movements

  • Today's Low: $2.61
    Today's High: $2.78

    Day's Volatility :6.12%

  • 52 Weeks Low: $1.61
    52 Weeks High: $4.62

    52 Weeks Volatility :65.15%

Proqr Therapeutics Nv Returns

PeriodProqr Therapeutics NvSector (Health Care)Index (Russel 2000)
3 Months
47.59%
-8.4%
0.0%
6 Months
63.31%
-3.8%
0.0%
1 Year
38.69%
-0.1%
0.0%
3 Years
-60.63%
2.9%
-19.8%

Proqr Therapeutics Nv Key Statistics

in dollars & INR

Previous Close
$2.76
Open
$2.75
Today's High
$2.78
Today's Low
$2.61
Market Capitalization
$280.7M
Today's Volume
$180.6K
52 Week High
$4.62
52 Week Low
$1.61
Revenue TTM
$18.4M
EBITDA
$-28.6M
Earnings Per Share (EPS)
$-0.31
Profit Margin
-130.21%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-67.14%

How to invest in Proqr Therapeutics Nv from India?

It is very easy for Indian residents to invest directly in Proqr Therapeutics Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Proqr Therapeutics Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Proqr Therapeutics Nv or PRQR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Proqr Therapeutics Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Proqr Therapeutics Nv shares which would translate to 0.328 fractional shares of Proqr Therapeutics Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Proqr Therapeutics Nv, in just a few clicks!

Returns in Proqr Therapeutics Nv for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Proqr Therapeutics Nv investment value today

Current value as on today

₹1,34,881

Returns

₹34,881

(+34.88%)

Returns from Proqr Therapeutics Nv Stock

₹31,658 (+31.66%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Proqr Therapeutics Nv

-42%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Proqr Therapeutics Nv on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -42% less investors are searching Proqr Therapeutics Nv in the last 30 days versus the previous period.

Global Institutional Holdings in Proqr Therapeutics Nv

  • Privium Fund Management B.V.

    5.32%

  • Adage Capital Partners Gp LLC

    3.42%

  • EcoR1 Capital, LLC

    1.73%

  • M28 Capital Management LP

    0.96%

  • Dafna Capital Management LLC

    0.86%

  • Ghost Tree Capital, LLC

    0.84%

Analyst Recommendation on Proqr Therapeutics Nv

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Proqr Therapeutics Nv(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Proqr Therapeutics Nv

What analysts predicted

Upside of 205.34%

Current:

$2.62

Target:

$8.00

Insights on Proqr Therapeutics Nv

  • Price Movement

    In the last 1 month, PRQR stock has moved down by -22.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 6.33M → 3.84M (in $), with an average decrease of 39.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.69M → -8.10M (in $), with an average decrease of 201.2% per quarter
  • PRQR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 116.9%

Proqr Therapeutics Nv Financials in INR & Dollars

FY18Y/Y Change
Revenue
$5.6M
↓ 423.15%
Net Income
$-42.0M
↓ 15.45%
Net Profit Margin
-746.69%
↓ 3600.65%
FY19Y/Y Change
Revenue
$2.1M
↓ 60.88%
Net Income
$-63.1M
↑ 53.81%
Net Profit Margin
-2.9K%
↓ 2188.95%
FY20Y/Y Change
Revenue
$295.6K
↓ 87.43%
Net Income
$-56.7M
↓ 17.86%
Net Profit Margin
-19.2K%
↓ 16247.08%
FY21Y/Y Change
Revenue
$1.5M
↑ 457.2%
Net Income
$-69.7M
↑ 32.32%
Net Profit Margin
-4.6K%
↑ 14627.33%
FY22Y/Y Change
Revenue
$4.3M
↑ 198.15%
Net Income
$-68.7M
↑ 5.21%
Net Profit Margin
-1.6K%
↑ 2947.98%
FY23Y/Y Change
Revenue
$7.1M
↑ 61.36%
Net Income
$-30.7M
↓ 56.67%
Net Profit Margin
-431.67%
↑ 1175.74%
Q2 FY23Q/Q Change
Revenue
$1.3M
↑ 83.97%
Net Income
$-8.7M
↑ 0.03%
Net Profit Margin
-663.32%
↑ 556.68%
Q3 FY23Q/Q Change
Revenue
$1.5M
↑ 13.69%
Net Income
$-6.1M
↓ 28.56%
Net Profit Margin
-416.79%
↑ 246.53%
Q4 FY23Q/Q Change
Revenue
$3.5M
↑ 133.56%
Net Income
$-5.8M
↓ 6.44%
Net Profit Margin
-166.96%
↑ 249.83%
Q1 FY24Q/Q Change
Revenue
$4.9M
↑ 39.89%
Net Income
$-8.4M
↑ 44.19%
Net Profit Margin
-172.09%
↓ 5.13%
Q2 FY24Q/Q Change
Revenue
$6.8M
↑ 41.57%
Net Income
$-2.9M
↓ 65.05%
Net Profit Margin
-42.48%
↑ 129.61%
Q3 FY24Q/Q Change
Revenue
$3.8M
↓ 39.36%
Net Income
$-8.1M
↑ 201.19%
Net Profit Margin
-210.98%
↓ 168.5%
FY18Y/Y Change
Profit
$5.6M
↓ 423.15%
FY19Y/Y Change
Profit
$-127.7M
↓ 2425.24%
FY20Y/Y Change
Profit
$-2.7M
↓ 98.09%
FY21Y/Y Change
Profit
$1.5M
↓ 161.71%
FY22Y/Y Change
Profit
$1.7M
↑ 15.32%
FY23Y/Y Change
Profit
$7.0M
↑ 308.64%
Q2 FY23Q/Q Change
Profit
$1.3M
↑ 83.97%
Q3 FY23Q/Q Change
Profit
$1.5M
↑ 13.69%
Q4 FY23Q/Q Change
Profit
$3.5M
↑ 133.56%
Q1 FY24Q/Q Change
Profit
$4.1M
↑ 18.17%
Q2 FY24Q/Q Change
Profit
$6.0M
↑ 48.69%
Q3 FY24Q/Q Change
Profit
$3.8M
↓ 31.65%
FY18Y/Y Change
Operating Cash Flow
$-34.9M
↓ 12.21%
Investing Cash Flow
$-354.9K
↑ 157.85%
Financing Cash Flow
$100.8M
↑ 232.76%
FY19Y/Y Change
Operating Cash Flow
$-48.9M
↑ 43.31%
Investing Cash Flow
$-644.5K
↑ 85.9%
Financing Cash Flow
$55.8M
↓ 43.37%
FY20Y/Y Change
Operating Cash Flow
$-57.2M
↑ 7.03%
Investing Cash Flow
$-1.1M
↑ 59.31%
Financing Cash Flow
$17.6M
↓ 71.11%
FY21Y/Y Change
Operating Cash Flow
$-29.4M
↓ 44.73%
Investing Cash Flow
$-480.4K
↓ 54.0%
Financing Cash Flow
$154.7M
↑ 843.67%
FY22Y/Y Change
Operating Cash Flow
$-72.5M
↑ 163.37%
Investing Cash Flow
$-742.9K
↑ 65.18%
Financing Cash Flow
$-32.7M
↓ 122.58%
Q2 FY23Q/Q Change
Operating Cash Flow
$-11.2M
↓ 123.13%
Investing Cash Flow
$-318.9K
↑ 0.0%
Financing Cash Flow
$-697.5K
↑ 148.26%

Proqr Therapeutics Nv Technicals Summary

Sell

Neutral

Buy

Proqr Therapeutics Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Proqr Therapeutics Nv Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Proqr Therapeutics Nv
-20.0%
63.31%
38.69%
-60.63%
-68.95%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Proqr Therapeutics Nv
NA
NA
0.0
-0.48
-0.67
-0.15
NA
0.31
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Proqr Therapeutics Nv
Buy
$280.7M
-68.95%
NA
-130.21%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Proqr Therapeutics Nv

proqr therapeutics is a leiden, nl based biotech company focused on developments of drugs to treat genetic disorders. based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. founded by industry icons and based on ground breaking science we strive to make a meaningful impact. check out our website for vacancies: www.proqr.com
Organization
Proqr Therapeutics Nv
Employees
156
CEO
Mr. Daniel Anton de Boer
Industry
Health Technology

Management People of Proqr Therapeutics Nv

NameTitle
Mr. Daniel Anton de Boer
Founder, CEO & Member of Management Board
Dr. Domenico Valerio Ph.D.
Founder & Independent Member of Supervisory Board
Mr. Rene K. Beukema
Chief Corporate Development Officer, General Counsel & Member of Management Board
Dr. Gerard Platenburg
Co-Founder, Chief Scientific Officer & Member of Management Board
Mr. Jurriaan Dekkers
Chief Financial Officer
Ms. Sheila Sponselee
Chief People & Operations Officer
Ms. Sarah Cue Kiely
Vice President of Investor Relations & Corporate Communications
Ms. Sandra van der Kolk
Junior Financial Controller

Important FAQs about investing in Proqr Therapeutics Nv from India :

What is Proqr Therapeutics Nv share price today?

Proqr Therapeutics Nv share price today stands at $2.62, Open: $2.75 ; Previous Close: $2.76 ; High: $2.78 ; Low: $2.61 ; 52 Week High: $4.62 ; 52 Week Low: $1.61. The stock opens at $2.75, after a previous close of $2.76. The stock reached a daily high of $2.78 and a low of $2.61, with a 52-week high of $4.62 and a 52-week low of $1.61.

Can Indians buy Proqr Therapeutics Nv shares?

Yes, Indians can invest in the Proqr Therapeutics Nv (PRQR) from India.

With INDmoney, you can buy Proqr Therapeutics Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Proqr Therapeutics Nv at zero transaction cost.

How can I buy Proqr Therapeutics Nv shares from India?

It is very easy to buy Proqr Therapeutics Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Proqr Therapeutics Nv be purchased?

Yes, you can buy fractional shares of Proqr Therapeutics Nv with INDmoney app.

What are the documents required to start investing in Proqr Therapeutics Nv stocks?

To start investing in Proqr Therapeutics Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Proqr Therapeutics Nv

Today’s highest price of Proqr Therapeutics Nv (PRQR) is $2.78.

Today’s lowest price of Proqr Therapeutics Nv (PRQR) is $2.61.

What is today's market capitalisation of Proqr Therapeutics Nv

Today's market capitalisation of Proqr Therapeutics Nv PRQR is 280.7M

What is the 52 Week High and Low Range of Proqr Therapeutics Nv

  • 52 Week High

    $4.62

  • 52 Week Low

    $1.61

What are the historical returns of Proqr Therapeutics Nv?

  • 1 Month Returns

    -20%

  • 3 Months Returns

    63.31%

  • 1 Year Returns

    38.69%

  • 5 Years Returns

    -68.95%

Who is the Chief Executive Officer (CEO) of Proqr Therapeutics Nv

Mr. Daniel Anton de Boer is the current Chief Executive Officer (CEO) of Proqr Therapeutics Nv.